T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis

doi:10.1084/jem.184.5.1791

This Article

Full Text (PDF)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Scotet, E.

Articles by Houssaint, E.

Search for Related Content

PubMed

PubMed Citation

Articles by Scotet, E.

Articles by Houssaint, E.

Pubmed/NCBI databases

Medline Plus Health Information
Substance via MeSH
Joint Disorders
Rheumatoid Arthritis

Social Bookmarking

What's this?

ARTICLES

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis

E Scotet, J David-Ameline, MA Peyrat, A Moreau-Aubry, D Pinczon, A Lim, J Even, G Semana, JM Berthelot, R Breathnach, M Bonneville and E Houssaint
Institut National de la Sante et de la Recherche Medicale U211, Institut de Biologie, Nantes, France.

Rheumatoid arthritis is a multistep disorder associated with autoimmune features of yet unknown etiology. Implication of viruses such as Epstein-Barr virus (EBV) in rheumatoid arthritis pathogenesis has been suspected on the basis of several indirect observations, but thus far, a direct link between EBV and rheumatoid arthritis has not been provided. Here we show that a large fraction of T cells infiltrating affected joints from a patient with chronic rheumatoid arthritis recognizes two EBV transactivators (BZLF1 and BMLF1) in a major histocompatibility complex-restricted fashion. Responses to these EBV antigens by synovial lymphocytes from several other chronic rheumatoid arthritis patients were readily detectable. Thus these results suggest a direct contribution of EBV to chronic rheumatoid arthritis pathogenesis. They also demonstrate for the first time the occurrence of T cell responses against EBV transactivating factors, which might be central in the control of virus reactivation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Lunemann, J. D., Frey, O., Eidner, T., Baier, M., Roberts, S., Sashihara, J., Volkmer, R., Cohen, J. I., Hein, G., Kamradt, T., Munz, C. (2008). Increased Frequency of EBV-Specific Effector Memory CD8+ T Cells Correlates with Higher Viral Load in Rheumatoid Arthritis. J. Immunol. 181: 991-1000 [Abstract] [Full Text]
Hislop, A. D., Ressing, M. E., van Leeuwen, D., Pudney, V. A., Horst, D., Koppers-Lalic, D., Croft, N. P., Neefjes, J. J., Rickinson, A. B., Wiertz, E. J.H.J. (2007). A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J. Exp. Med. 204: 1863-1873 [Abstract] [Full Text]
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J., Khanna, R. (2006). Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 108: 2280-2289 [Abstract] [Full Text]
Wang, H., Nicholas, M. W., Conway, K. L., Sen, P., Diz, R., Tisch, R. M., Clarke, S. H. (2006). EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity.. J. Immunol. 177: 2793-2802 [Abstract] [Full Text]
Sauce, D., Larsen, M., Curnow, S. J., Leese, A. M., Moss, P. A. H., Hislop, A. D., Salmon, M., Rickinson, A. B. (2006). EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood 108: 11-18 [Abstract] [Full Text]
Fogg, M. H., Garry, D., Awad, A., Wang, F., Kaur, A. (2006). The BZLF1 Homolog of an Epstein-Barr-Related {gamma}-Herpesvirus Is a Frequent Target of the CTL Response in Persistently Infected Rhesus Macaques. J. Immunol. 176: 3391-3401 [Abstract] [Full Text]
Landais, E., Saulquin, X., Bonneville, M., Houssaint, E. (2005). Long-Term MHC Class II Presentation of the EBV Lytic Protein BHRF1 by EBV Latently Infected B Cells following Capture of BHRF1 Antigen. J. Immunol. 175: 7939-7946 [Abstract] [Full Text]
Trautmann, L., Rimbert, M., Echasserieau, K., Saulquin, X., Neveu, B., Dechanet, J., Cerundolo, V., Bonneville, M. (2005). Selection of T Cell Clones Expressing High-Affinity Public TCRs within Human Cytomegalovirus-Specific CD8 T Cell Responses. J. Immunol. 175: 6123-6132 [Abstract] [Full Text]
Wooldridge, L., van den Berg, H. A., Glick, M., Gostick, E., Laugel, B., Hutchinson, S. L., Milicic, A., Brenchley, J. M., Douek, D. C., Price, D. A., Sewell, A. K. (2005). Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell Surface. J. Biol. Chem. 280: 27491-27501 [Abstract] [Full Text]
Seggewiss, R., Lore, K., Greiner, E., Magnusson, M. K., Price, D. A., Douek, D. C., Dunbar, C. E., Wiestner, A. (2005). Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 105: 2473-2479 [Abstract] [Full Text]
Pudney, V. A., Leese, A. M., Rickinson, A. B., Hislop, A. D. (2005). CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. J. Exp. Med. 201: 349-360 [Abstract] [Full Text]
Yarilin, D. A., Valiando, J., Posnett, D. N. (2004). A Mouse Herpesvirus Induces Relapse of Experimental Autoimmune Arthritis by Infection of the Inflammatory Target Tissue. J. Immunol. 173: 5238-5246 [Abstract] [Full Text]
Guerreiro-Cacais, A. O., Li, L., Donati, D., Bejarano, M. T., Morgan, A., Masucci, M. G., Hutt-Fletcher, L., Levitsky, V. (2004). Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J. Gen. Virol. 85: 2767-2778 [Abstract] [Full Text]
Wang, Z., La Rosa, C., Mekhoubad, S., Lacey, S. F., Villacres, M. C., Markel, S., Longmate, J., Ellenhorn, J. D. I., Siliciano, R. F., Buck, C., Britt, W. J., Diamond, D. J. (2004). Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood 104: 847-856 [Abstract] [Full Text]
Landais, E., Saulquin, X., Scotet, E., Trautmann, L., Peyrat, M.-A., Yates, J. L., Kwok, W. W., Bonneville, M., Houssaint, E. (2004). Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Blood 103: 1408-1416 [Abstract] [Full Text]
Sidney, J., Southwood, S., Pasquetto, V., Sette, A. (2003). Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype. J. Immunol. 171: 5964-5974 [Abstract] [Full Text]
Kang, Y. M., Zhang, X., Wagner, U. G., Yang, H., Beckenbaugh, R. D., Kurtin, P. J., Goronzy, J. J., Weyand, C. M. (2002). CD8 T Cells Are Required for the Formation of Ectopic Germinal Centers in Rheumatoid Synovitis. J. Exp. Med. 195: 1325-1336 [Abstract] [Full Text]
Davenport, M. P., Fazou, C., McMichael, A. J., Callan, M. F. C. (2002). Clonal Selection, Clonal Senescence, and Clonal Succession: The Evolution of the T Cell Response to Infection with a Persistent Virus. J. Immunol. 168: 3309-3317 [Abstract] [Full Text]
Catalina, M. D., Sullivan, J. L., Bak, K. R., Luzuriaga, K. (2001). Differential Evolution and Stability of Epitope-Specific CD8+ T Cell Responses in EBV Infection. J. Immunol. 167: 4450-4457 [Abstract] [Full Text]
Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., Weyand, C. M. (2001). T Cell Activation in Rheumatoid Synovium Is B Cell Dependent. J. Immunol. 167: 4710-4718 [Abstract] [Full Text]
Hislop, A. D., Gudgeon, N. H., Callan, M. F. C., Fazou, C., Hasegawa, H., Salmon, M., Rickinson, A. B. (2001). EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function. J. Immunol. 167: 2019-2029 [Abstract] [Full Text]
Vely, F., Peyrat, M.-A., Couedel, C., Morcet, J.-F., Halary, F., Davodeau, F., Romagne, F., Scotet, E., Saulquin, X., Houssaint, E., Schleinitz, N., Moretta, A., Vivier, E., Bonneville, M. (2001). Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements. J. Immunol. 166: 2487-2494 [Abstract] [Full Text]
Lim, A., Trautmann, L., Peyrat, M.-A., Couedel, C., Davodeau, F., Romagne, F., Kourilsky, P., Bonneville, M. (2000). Frequent Contribution of T Cell Clonotypes with Public TCR Features to the Chronic Response Against a Dominant EBV-Derived Epitope: Application to Direct Detection of Their Molecular Imprint on the Human Peripheral T Cell Repertoire. J. Immunol. 165: 2001-2011 [Abstract] [Full Text]
Mollet, L., Li, T.-S., Samri, A., Tournay, C., Tubiana, R., Calvez, V., Debre, P., Katlama, C., Autran, B. (2000). Dynamics of HIV-Specific CD8+ T Lymphocytes with Changes in Viral Load. J. Immunol. 165: 1692-1704 [Abstract] [Full Text]
Dukers, D. F., Meij, P., Vervoort, M. B. H. J., Vos, W., Scheper, R. J., Meijer, C. J. L. M., Bloemena, E., Middeldorp, J. M. (2000). Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1. J. Immunol. 165: 663-670 [Abstract] [Full Text]
Toussirot, E., Wendling, D., Tiberghien, P., Luka, J., Roudier, J. (2000). Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis 59: 533-538 [Abstract] [Full Text]
Aarvak, T., Chabaud, M., Thoen, J., Miossec, P., Natvig, J. B. (2000). Changes in the Th1 or Th2 cytokine dominance in the synovium of rheumatoid arthritis (RA): a kinetic study of the Th subsets in one unusual RA patient. Rheumatology (Oxford) 39: 513-522 [Abstract] [Full Text]
Hoshino, Y., Morishima, T., Kimura, H., Nishikawa, K., Tsurumi, T., Kuzushima, K. (1999). Antigen-Driven Expansion and Contraction of CD8+-Activated T Cells in Primary EBV Infection. J. Immunol. 163: 5735-5740 [Abstract] [Full Text]
Wei, C.-H., Beeson, C., Masucci, M. G., Levitsky, V. (1999). A Partially Agonistic Peptide Acts as a Selective Inducer of Apoptosis in CD8+ CTLs. J. Immunol. 163: 2601-2609 [Abstract] [Full Text]
Couedel, C., Bodinier, M., Peyrat, M.-A., Bonneville, M., Davodeau, F., Lang, F. (1999). Selection and Long-Term Persistence of Reactive CTL Clones During an EBV Chronic Response Are Determined by Avidity, CD8 Variable Contribution Compensating for Differences in TCR Affinities. J. Immunol. 162: 6351-6358 [Abstract] [Full Text]
Dulphy, N., Peyrat, M.-A., Tieng, V., Douay, C., Rabian, C., Tamouza, R., Laoussadi, S., Berenbaum, F., Chabot, A., Bonneville, M., Charron, D., Toubert, A. (1999). Common Intra-Articular T Cell Expansions in Patients with Reactive Arthritis: Identical {beta}-Chain Junctional Sequences and Cytotoxicity Toward HLA-B27. J. Immunol. 162: 3830-3839 [Abstract] [Full Text]
Edinger, J. W., Bonneville, M., Scotet, E., Houssaint, E., Schumacher, H. R., Posnett, D. N. (1999). EBV Gene Expression Not Altered in Rheumatoid Synovia Despite the Presence of EBV Antigen-Specific T Cell Clones. J. Immunol. 162: 3694-3701 [Abstract] [Full Text]
Misko, I. S., Cross, S. M., Khanna, R., Elliott, S. L., Schmidt, C., Pye, S. J., Silins, S. L. (1999). Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease. Proc. Natl. Acad. Sci. USA 96: 2279-2284 [Abstract] [Full Text]
Sallusto, F., Lanzavecchia, A. (1999). Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation. J. Exp. Med. 189: 611-614 [Full Text]
Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O'Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., Callan, M. F. C. (1999). A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers. J. Immunol. 162: 1827-1835 [Abstract] [Full Text]
Redchenko, I. V., Rickinson, A. B. (1999). Accessing Epstein-Barr Virus-Specific T-Cell Memory with Peptide-Loaded Dendritic Cells. J. Virol. 73: 334-342 [Abstract] [Full Text]
van Sechel, A. C., van Stipdonk, M. J. B., Persoon-Deen, C., Geutskens, S. B., van Noort, J. M. (1999). EBV-Induced Expression and HLA-DR-Restricted Presentation by Human B Cells of {alpha}B-Crystallin, a Candidate Autoantigen in Multiple Sclerosis. J. Immunol. 162: 129-135 [Abstract] [Full Text]
Striebich, C. C., Falta, M. T., Wang, Y., Bill, J., Kotzin, B. L. (1998). Selective Accumulation of Related CD4+ T Cell Clones in the Synovial Fluid of Patients with Rheumatoid Arthritis. J. Immunol. 161: 4428-4436 [Abstract] [Full Text]
Ruchatz, H., Leung, B. P., Wei, X.-q., McInnes, I. B., Liew, F. Y. (1998). Soluble IL-15 Receptor {alpha}-Chain Administration Prevents Murine Collagen-Induced Arthritis: A Role for IL-15 in Development of Antigen-Induced Immunopathology. J. Immunol. 160: 5654-5660 [Abstract] [Full Text]
Callan, M.F.C., Tan, L., Annels, N., Ogg, G.S., Wilson, J.D.K., O'Callaghan, C.A., Steven, N., McMichael, A.J., Rickinson, A.B. (1998). Direct Visualization of Antigen-specific CD8+ T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo. J. Exp. Med. 187: 1395-1402 [Abstract] [Full Text]
BOERBOOMS;, A. M T H, BERTHELOT, J-M (1997). Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled. Ann Rheum Dis 56: 395a-396 [Full Text]
Posnett, D. N., Edinger, J. (1997). When Do Microbes Stimulate Rheumatoid Factor?. J. Exp. Med. 185: 1721-1723 [Full Text]
Steven, N.M., Annels, N.E., Kumar, A., Leese, A.M., Kurilla, M.G., Rickinson, A.B. (1997). Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus-induced Cytotoxic T Cell Response. J. Exp. Med. 185: 1605-1618 [Abstract] [Full Text]
Hislop, A. D., Annels, N. E., Gudgeon, N. H., Leese, A. M., Rickinson, A. B. (2002). Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection. J. Exp. Med. 195: 893-905 [Abstract] [Full Text]